Cocrystal Pharma Will Ride A Wave Of Clinical Trial Success

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, hepatitis C viruses, coronaviruses and noroviruses. They have a proprietary structural biology, enzymology and medicinal chemistry expertise enables Cocrystal Pharma to develop novel antiviral agents. These technologies and our market-focused approach to drug discovery are designed to effectively create small molecule therapeutics that are safe, effective and convenient to administer.

back

Cocrystal Pharma Will Ride A Wave Of Clinical Trial Success

bullish
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, hepatitis C viruses, coronaviruses and noroviruses. They have a proprietary structural biology, enzymology and medicinal chemistry expertise enables Cocrystal Pharma to develop novel antiviral agents. These technologies and our market-focused approach to drug discovery are designed to effectively create small molecule therapeutics that are safe, effective and convenient to administer.
Comments

Write your comment....

Sign in to comment

read-time
< 1 min

2.10

Target Price

8/ 10

Confidence

2-6 Months

Timeframe
Share
catalyst icon
Earnings Release
catalyst icon
News
catalyst icon
SEC Filing
catalyst icon
Sentiment
catalyst icon
Other Catalyst

COCP Channel

Start new chat
aiodd-ad
next